Price
No data yet.
Social Signal Score
Analyst Ratings
16 analystsRevenue
$416.24M+163.92%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Martha Goldberg Aronson
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 7,500
- Beta
- 0.55
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 4.23
Financials
Revenue
$416.24M+163.9%Net Income
$42.31M+463.7%EBITDA
$94.96M+288.2%Free Cash Flow
$52.25M+407.6%EPS (diluted)
$0.70+311.8%Shares Outstanding (diluted)
60.38M+33.7%Operating Expenses
$141.90MCash & Debt
$503.55MRevenue by Segment (annual)
$1.52BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.51B | $128.49M | $2.17 |
| 2024 | $1.36B | $120.36M | $2.07 |
| 2023 | $1.26B | $94.41M | $1.64 |
| 2022 | $1.15B | $74.52M | $1.31 |
| 2021 | $1.07B | $48.45M | $0.86 |
| 2020 | $963.88M | $-9.84M | $-0.18 |
| 2019 | $994.85M | $5.45M | $0.10 |
| 2018 | $882.75M | $42.02M | $0.80 |
| 2017 | $727.85M | $27.52M | $0.56 |
| 2016 | $603.84M | $20.12M | $0.45 |
| 2015 | $542.15M | $23.80M | $0.54 |
| 2014 | $509.69M | $22.97M | $0.53 |
| 2013 | $449.05M | $16.57M | $0.39 |
| 2012 | $394.29M | $19.71M | $0.47 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from MMSI's reported EPS growth of 12.5% a year over 13 years.
- EPS in 5 years
- $3.91
- Implied price
- $160.47
- Return from $84.34
- 13.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $79.78 — -5.4% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 29 | 35 | 41 | 47 | 53 |
|---|---|---|---|---|---|
| 2.5% | -3.3% | 0.4% | 3.6% | 6.5% | 9.1% |
| 7.5% | 1.4% | 5.3% | 8.7% | 11.7% | 14.4% |
| 12.5% | 6.1% | 10.2% | 13.7% | 16.9% | 19.7% |
| 17.5% | 10.8% | 15.1% | 18.8% | 22.1% | 25.0% |
| 22.5% | 15.6% | 20.0% | 23.8% | 27.3% | 30.4% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+2.27%Social Signal Score
Mentions (34)
- News (RSS)seekingalpha·5d ago·Neutral
Eastern Bankshares' Recent Results Merit Continued Optimism
View source ↗ - News (RSS)seekingalpha·13d ago·Neutral
Fluor: Despite High Backlog, Enough Potential Headwinds To Merit Caution
View source ↗ - Newszacks.com·16d ago·Positive
Here's Why You Should Retain MMSI Stock in Your Portfolio for Now Merit Medical's strong product demand, innovation and acquisitions fuel growth, while tariffs, China market pressures and competition remain key challenges.
View source ↗ - News (RSS)seekingalpha·22d ago·Neutral
Merit Medical Systems: A Solid Q3, While Adding New Growth Engines
View source ↗ - News (Marketaux)seekingalpha.com·22d ago·Positive
Merit Medical Stock: A Solid Q3, While Adding New Growth Engines (NASDAQ:MMSI) In May I believed that Merit <e[+330 characters]
View source ↗ - News (RSS)seekingalpha·23d ago·Neutral
Merit Medical targets $4.33-$4.37 non-GAAP EPS in 2026 while adding Solo Pace for ~$45M
View source ↗ - News (RSS)seekingalpha·23d ago·Positive
Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
View source ↗ - Newsseekingalpha.com·24d ago·Positive
Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
View source ↗ - News (RSS)investing·24d ago·Neutral
Merit Medical Q3 2026 slides: revenue up 8%, guidance raised
View source ↗ - Newsmarketbeat.com·24d ago·Neutral
Merit Medical Systems Q3 Earnings Call Highlights Merit Medical Systems NASDAQ: MMSI reported third-quarter 2026 revenue of $416 million, up 8% year over year on both a GAAP and constant-currency basis, as organic constant-currency growth reached 9% and exceeded management's prior expectations.
View source ↗ - Newszacks.com·24d ago·Positive
Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates Merit Medical (MMSI) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $1.04 per share. This compares to earnings of $0.92 per share a year ago.
View source ↗ - Newszacks.com·24d ago·Neutral
Merit Medical (MMSI) Reports Q3 Earnings: What Key Metrics Have to Say Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newsglobenewswire.com·24d ago·Negative
Merit Medical Reports Third Quarter 2026 Results: Delivers 9% Organic Constant Currency Revenue Growth and Raises Full-Year 2026 Guidance Financial Highlights† Reported revenue of $416.2 million, up 8.4% Constant currency revenue* and constant currency revenue, organic* up 8% and up 9%, respectively GAAP operating margin of 14.1%, compared to 11.1% in prior year period Non-GAAP operating margin* of 21.3%, compared to 19.7% in prior year period GAAP EPS $0.70, up 51% Non-GAAP EPS* $1.12, up 22% C
View source ↗ - Newsglobenewswire.com·24d ago·Neutral
Merit Medical Acquires Solo Pace, Inc., Expanding Its Cardiac Therapies Platform with Innovative TAVR Pacing Technology SOUTH JORDAN, Utah, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced its acquisition of Solo Pace, Inc. (Solo Pace). Located in Minneapolis, Minnesota, Solo Pace manufactures temporary pacing technology designed to help physicians treat patients with aortic stenosis.
View source ↗ - News (RSS)zerohedge·26d ago·Neutral
One Big Club Update: Judge Rules DOJ Unlawfully Fired Epstein Prosecutor Maurene Comey, Orders Her Reinstated One Big Club Update: Judge Rules DOJ Unlawfully Fired Epstein Prosecutor Maurene Comey, Orders Her Reinstated A federal judge ruled Monday that the Justice Department unlawfully fired Maurene Comey, the former Manhattan federal prosecutor who worked on the Jeffrey Epstein and Ghislaine Maxwell cases and the daughter of ex-FBI Director James Comey, and ordered her reinstated retroactively
View source ↗ - News (RSS)investing·27d ago·Neutral
Merit Medical Systems stock hits 52-week high at 94.79 USD
View source ↗ - News (RSS)zerohedge·37d ago·Neutral
Justice Alito: Originalist In Full Justice Alito: Originalist In Full Authored by Cully Stimson via The Epoch Times, Justice Samuel A. Alito's new book, "So Ordered: An Originalist's View of the Constitution, the Court, and Our Country," is not a conventional judicial memoir - and that is precisely its strength. It is a carefully curated collection of 19 lectures and speeches delivered between 2007 and 2025 on subjects constitutional and cultural, solemn and unexpectedly personal. Organized arou
View source ↗ - News (RSS)financialpost·39d ago·Neutral
Regula Identity Verification Platform Wins 2026 Merit Technology Award RESTON, Va., Oct. 14, 2026 (GLOBE NEWSWIRE) — Regula IDV Platform has received an award in the Identity, Access Management (IAM) & Authentication subcategory of the 2026 Merit Technology Awards. Designed for organizations in high-risk industries, Regula IDV Platform is an enterprise-grade identity lifecycle management solution. It combines document and biometric verification with configurable risk-based […]
View source ↗ - News (RSS)hellenicshipping·42d ago·Neutral
Sanctioned ships taking Nicaraguan numbers are doing it near Hormuz Between 1 August and 26 September we heard 10 listed ships switch to a Nicaraguan MMSI, and 8 of them were first heard on the new number in one box around the Strait of Hormuz. No other new flag comes close. None of the new numbers is one a list publishes. A ship’s MMSI is ...
View source ↗ - Newsglobenewswire.com·47d ago·Neutral
…Medical Systems to Announce Third Quarter 2026 Results on October 29, 2026 SOUTH JORDAN, Utah, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2026, after the close of the stock market on Thursday, October 29, 2026. Merit plans to hold its investor conference call on the same day (Thursday, October 29, 2026) at 4:30 p.m. Eastern (3…
View source ↗ - Newszacks.com·47d ago·Neutral
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now MMSI's broad product portfolio, global expansion and strategic M&A support growth, while tariffs and China pressures remain key risks.
View source ↗ - Newsdefenseworld.net·59d ago·Neutral
Financial Survey: Merit Medical Systems (NASDAQ:MMSI) vs. Bausch + Lomb (NYSE:BLCO) Merit Medical Systems (NASDAQ: MMSI - Get Free Report) and Bausch + Lomb (NYSE: BLCO - Get Free Report) are both mid-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk. Institutional and Insider Ownership 99.7%
View source ↗ - News (RSS)financialpost·76d ago·Negative
ICBA and Global eTraining Launch Construction Technology Training Initiative to Upskill Canadian Contractors ICBA deploys an on-demand technical training initiative, establishing an industry-leading construction technology training platform for ICBA and Merit Canada members SURREY, British Columbia, Sept. 07, 2026 (GLOBE NEWSWIRE) — The Independent Contractors and Businesses Association (ICBA) today announced a major construction technology training initiative in collaboration with Global eTrain
View source ↗ - Newsglobenewswire.com·79d ago·Neutral
Merit Medical to Participate in Upcoming Investors Conferences in September SOUTH JORDAN, Utah, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader in healthcare technology, today announced that management is scheduled to participate in the following upcoming investor conferences:
View source ↗ - Newszacks.com·81d ago·Neutral
Here's Why You Should Add Merit Medical Stock to Your Portfolio Now MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.
View source ↗ - News (RSS)zerohedge·83d ago·Neutral
No Whites Allowed, Britain's MI5 Tells Applicants No Whites Allowed, Britain's MI5 Tells Applicants Authored by Steve Watson via Modernity News, Britain's domestic intelligence service is once again telling White university students they are not wanted. For the 2027 Summer Intelligence Internship, MI5 has confined applications to people from a "black, Asian, mixed heritage or ethnic minority background" who also come from a "socially or economically disadvantaged background." White British candi
View source ↗ - Newszacks.com·90d ago·Positive
Should You Buy MMSI as Growth Improves but Valuation Stays Elevated? Merit Medical's growth case is strengthening as launches, acquisitions and therapeutic products broaden its mix, but its premium valuation raises the execution bar.
View source ↗ - Newszacks.com·90d ago·Positive
Can MMSI Sustain Its 22.2% Gain in the Past Month as Growth Improves? Merit Medical's 22.2% monthly rally gains support from stronger Q2 growth and a raised 2026 outlook, but valuation and tariff risks remain.
View source ↗ - Newszacks.com·94d ago·Positive
Here's Why Merit Medical (MMSI) is a Strong Momentum Stock Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (RSS)zerohedge·96d ago·Negative
Deep Capture: The Administrative State's Intellectual Origins Deep Capture: The Administrative State's Intellectual Origins Authored by Sofia Karstens via Brownstone Institute, Woodrow Wilson holds a distinction no other American president has: he earned a Ph.D., completing his doctorate in political science and history at Johns Hopkins University in 1886. That same year, he wrote an essay called "The Study of Administration," later published in the inaugural volume of Political Science Quarterl
View source ↗ - Newsmarketbeat.com·99d ago·Positive
Merit Medical Eyes Next Growth Plan as Margins, Portfolio Review Take Center Stage Merit Medical Systems NASDAQ: MMSI is focused on completing the objectives of its current long-range plan while developing its next strategic framework, Chief Financial Officer and Treasurer Raul Parra said during a Canaccord investor event.
View source ↗ - Newsmarketbeat.com·99d ago·Positive
Merit Medical Systems Eyes New Long-Range Plan as Growth, Margins Gain Momentum Merit Medical Systems NASDAQ: MMSI is preparing its next long-range plan as the medical-device company works through a leadership transition, updates its reporting structure and seeks to build on recent revenue and margin momentum.
View source ↗ - News (RSS)seekingalpha·102d ago·Positive
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
View source ↗ - Newsseekingalpha.com·102d ago·Positive
Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript Merit Medical Systems, Inc. (MMSI) Presents at Bank of America SMID Cap Virtual Conference Transcript
View source ↗
Earnings
Tue, Feb 23(in 3 months)
Consensus estimate $1.11 per share
Typical surprise +12.2% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Oct 29$1.12 vs $1.04beat
- Thu, Jul 30$1.19 vs $0.96beat
- Thu, Apr 30$0.94 vs $0.84beat
- Tue, Feb 24$1.04 vs $0.96beat
- Thu, Oct 30$0.92 vs $0.82beat
- Wed, Jul 30$1.01 vs $0.86beat
Estimates and results for MMSI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by MMSI officers and directors.
- Bought
- $573k
- Sold
- $18.4m
5 trades
20 trades
- Lloyd Brian G.sold
- Peterson Neil W.sold
- Peterson Neil W.sold
- Smith Christian Adambought
- Ward Lynne N.sold
- Lloyd Brian G.bought
- Aronson Martha Goldbergbought
- Parra Raul Jr.bought
75 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (27d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
